Previous Article | Next Article 
Applied and Environmental Microbiology, December 2001, p. 5721-5728, Vol. 67, No. 12
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.12.5721-5728.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differential Synthesis of Peritoxins and Precursors by Pathogenic
Strains of the Fungus Periconia circinata
Alice C. L.
Churchill,1,*
Larry D.
Dunkle,2
Walter
Silbert,1,
Kevin J.
Kennedy,1,
and
Vlado
Macko1
Boyce Thompson Institute, Cornell University, Ithaca, New
York 14853-1801,1 and USDA-Agricultural
Research Service, Department of Botany and Plant Pathology, Purdue
University, West Lafayette, Indiana 47907-11552
Received 7 March 2001/Accepted 20 September 2001
 |
ABSTRACT |
Pathogenic strains of the soilborne fungus Periconia
circinata produce peritoxins with host-selective toxicity
against susceptible genotypes of sorghum. The peritoxins are
low-molecular-weight, hybrid molecules consisting of a peptide and a
chlorinated polyketide. Culture fluids from pathogenic, toxin-producing
(Tox+) and nonpathogenic, non-toxin-producing
(Tox
) strains were analyzed directly by gradient
high-performance liquid chromatography (HPLC) with photodiode array
detection and HPLC-mass spectrometry to detect intermediates and final
products of the biosynthetic pathway. This approach allowed us to
compare the metabolite profiles of Tox+ and
Tox
strains. Peritoxins A and B and the biologically
inactive intermediates, N-3-(E-pentenyl)-glutaroyl-aspartate,
circinatin, and 7-chlorocircinatin, were detected only in culture
fluids of the Tox+ strains. The latter two compounds were
produced consistently by Tox+ strains regardless of the
amount of peritoxins produced under various culture conditions. In
summary, none of the known peritoxin-related metabolites were detected
in Tox
strains, which suggests that these strains may
lack one or more functional genes required for peritoxin biosynthesis.
 |
INTRODUCTION |
Milo disease, a root and
crown rot caused by the soilborne fungus Periconia circinata
(Mangin) Sacc., was the first major threat to the cultivation of
sorghum (Sorghum bicolor [L.]) in North America
(14). The majority of sorghums introduced into the
south-central United States from Africa were representatives of the
milo race with several desirable agronomic characteristics, including
drought tolerance (8). These introductions were
susceptible to P. circinata and were nearly
devastated by milo disease during the 1920s and 1930s
(14). High-frequency, spontaneous mutations in the
semidominant allele at the Pc locus (21) led to
the development in the 1930s of resistant genotypes, which remain the
primary strategy for the control of milo disease today
(8).
Pathogenic strains of P. circinata produce
peritoxins, which are low-molecular-weight, hybrid molecules consisting
of a peptide and a chlorinated polyketide (2, 16).
Peritoxins exhibit host-selective toxicity at concentrations as low as
1 ng ml
1 against sorghum genotypes that are
susceptible to the pathogen (16, 26). Treatment of sorghum
seedlings with culture filtrates or purified preparations of toxin
reproduces the biochemical and visible symptoms of the disease in a
genotype-specific manner (6, 7, 9, 23, 27). Strains that
lack the ability to produce peritoxins are nonpathogenic (7, 19,
20). Thus, the pathogenic ability of P. circinata is strictly dependent upon its ability to produce
peritoxin, which in turn is the determinant of the disease phenotype
(8).
Non-toxin-producing (Tox
) strains of the fungus
are distributed throughout the temperate regions of the world, but
toxin-producing (Tox+) strains are known to occur
only in regions of the United States coincident with the occurrence of
milo disease (7). Peritoxin-producing ability apparently
increased the pathological niche of P. circinata by enabling it to parasitize a single genotype of sorghum, which is the
only species known to be a host. The possibility that milo disease
arose suddenly as the result of a mutation in a previously benign,
saprophytic population of P. circinata was
dismissed by Odvody et al. (19) because the disease
developed over a wide geographic area of the United States within a
very short period. Furthermore, the fungus has not mutated to races
that are pathogenic to other genotypes or groups of sorghum during the
past 70 years (8).
One approach to studies of toxin biosynthesis is to analyze the
metabolite profiles of toxin-producing and non-toxin-producing strains.
A mutation in a single gene that inactivates a single enzyme in the
biosynthetic pathway could result in the accumulation of the
intermediate that is the substrate of the defective enzyme or in
complete loss of production of all metabolites in the pathway, if a
regulatory gene is inactivated. The latter result could also occur if
multiple enzymes (or enzymatic activities) are encoded by genes in a
gene cluster (11) that is not found in non-toxin-producing strains. Such deletions occur in the maize pathogens Cochliobolus heterostrophus and Cochliobolus carbonum, in which only
the highly virulent, toxin-producing races possess the genes required
for the biosynthesis of their respective host-selective toxins; weakly virulent pathogens are missing the entire biosynthetic pathway (1, 3, 4, 13, 25, 28).
The primary objective of this research was to determine whether
nonpathogenic strains of P. circinata synthesize
and accumulate known metabolic intermediates in the pathway committed
to the biosynthesis of peritoxins. Do Tox
strains synthesize peritoxins in such low quantities relative to
Tox+ strains that toxin concentrations are not
high enough to elicit disease symptoms? Do Tox
strains synthesize only the inactive metabolites in the peritoxin biosynthetic pathway or no pathway intermediates at all? In order to
address these questions, a secondary objective was to evaluate culture
conditions to determine those most likely to support the production of
peritoxins and their precursors in any strain capable of making such
compounds. Our results provide the basis for subsequent molecular
approaches to characterize the genes for peritoxin biosynthesis in
P. circinata and to determine whether they are
absent or mutated in nonpathogenic, nontoxigenic strains.
 |
MATERIALS AND METHODS |
Culture and bioassays of P.
circinata.
Single conidiophore isolates of
P. circinata were obtained from infected roots of
field-grown sorghum collected in Texas, Kansas, and California (Table
1). The strains were grown and maintained
on potato dextrose agar (Difco, Detroit, Mich.) in the dark at 25°C
and stored on silica gel at 4°C (7) or as agar disks
(5-mm diameter) in a 65% glycerol solution at
70°C.
The strains used in this study are listed in Table
1, and
representative Tox
+ and
Tox

strains have been deposited in the American
Type Culture Collection
(ATCC 32725, ATCC 32726, ATCC 32727, and ATCC
32728). We determined
the pathogenicity of the strains as described
previously (
6,
7,
19) by growing seedlings of susceptible
or resistant sorghum
genotypes in a nutrient solution containing
conidia (3 × 10
2 to 5 × 10
2 ml
1) of the fungal
isolate or by planting sorghum seeds in soil or
vermiculite infested
with a mixture of conidia and
mycelium.
Culture fluids containing metabolites produced by the
Tox
+ and Tox

strains were
tested for their genotype-specific phytotoxicity
against intact
seedlings or excised leaves and by root growth
inhibition and
electrolyte leakage bioassays as described previously
(
6,
7,
8,
9,
16,
19). In the bioassays and the
pathogenicity tests,
near-isogenic cultivars `Colby' (
Pc Pc) and
`Resistant
Colby' (
pc pc) were used as the toxin-sensitive,
susceptible
genotype and toxin-insensitive, resistant genotype,
respectively
(
21).
For analyses of metabolites produced in culture,
P. circinata strains were grown by one of two methods. The
majority of the
assays were conducted with culture fluids harvested
from strains
grown in 16-oz, narrow-mouthed, glass prescription bottles
(Brockway
Glass Co., Inc., Brockway, Pa.) containing 100 ml of liquid
modified
Fries' medium supplemented with 0.1% yeast extract (MFY)
(
7,
20). Five disks (5-mm diameter) from the growing edge
of 5-
to 10-day-old cultures grown on potato dextrose agar plates were
cut with a cork borer and transferred to each prescription bottle,
which was incubated upright without agitation in the dark at 25°C
for
approximately 24 h with the bottle cap loosely tightened.
After
24 h, each bottle was incubated on its flattened side undisturbed
for at least 20 days. Fungal growth and toxin production were
most
consistent when the majority of the agar was removed from
each disk of
inoculum by cutting it away with a scalpel so that
the disks floated on
the surface of the liquid
medium.
An alternative culture method for in vitro toxin production was
examined. Disposable polystyrene tissue culture flasks with
a 0.2-µm
vented cap (Falcon no. 3107; Becton Dickinson, Franklin
Lakes, N.J.)
were used as culture vessels instead of prescription
bottles. Three
disks of inoculum (5-mm diameter) were transferred
to 14.4 ml of liquid
MFY and incubated as described above for
at least 12
days.
HPLC-DAD analyses of metabolites.
Culture fluids of
P. circinata were assayed over time by
high-performance liquid chromatography-diode array detection
(HPLC-DAD) for the purpose of determining the kinetics of
production of the known peritoxins and precursors. We developed a
method to analyze small volumes of culture fluids directly from growing
cultures without extensive purification steps. These studies allowed us to determine the time of maximal peritoxin production in each type of
culture vessel in order to most efficiently characterize the
differences among multiple Tox+ and
Tox
isolates.
Metabolites released into the culture medium were analyzed by HPLC with
a Waters Alliance 2690 Separations Module and a 996
Photodiode Array
Detector (HPLC-DAD). For each time point, approximately
1.5 ml of
culture fluid was transferred to a microcentrifuge tube,
and
cellular material was removed by centrifugation (16,000 ×
g) for 5 min at 4°C. Aliquots of culture fluid (100 µl)
were injected
by autosampler onto a C
18
reversed-phase column (Vydac 218TP54;
5-µm particle size; 4.6 by 250 mm). Samples were held at 4°C prior
to injection. Metabolites were
eluted with a gradient of 3 to
60% acetonitrile (in distilled water)
containing 0.1% trifluoroacetic
acid at 1 ml
min
1 over 60 min with the column temperature
held at 30°C. Authentic
peritoxins A and B (PtxA and PtxB,
respectively), circinatin,
7-chlorocircinatin (7-Cl-C), and
N-3-(
E-pentenyl)-glutaroyl-aspartate
(PGA) were
previously isolated in the laboratory of V. Macko (
2,
15,
16; V. Macko and D. Arigoni, unpublished data) and used
as
standards for this study. Since none of the authentic compounds
exhibited distinctive or useful absorbance spectra in the range
of 200 to 600 nm, the eluate was monitored by absorbance at 205
nm, near the
maximum absorbance for all of the compounds. Peaks
were identified by
coinjection of culture fluids with authentic
compounds or by separate
analyses of authentic compounds and samples,
followed by electronic
stacking of computer-generated chromatograms
for comparison of elution
times. The reproducibility of integration
of multiple peak areas and
heights was within 3 and 1%, respectively,
of the average when a
single compound was injected at three separate
times on the same day.
These values were within 8 and 5%, respectively,
of the average when a
sample of mixed standards was injected at
two different times,
approximately 1 year
apart.
For each isolate grown in tissue culture flasks, independent cultures
were grown and analyzed in triplicate for each time
point, or equal
aliquots of culture fluid from each replicate
were combined and
analyzed as one averaged sample. For prescription
bottle cultures,
triplicate samples from single cultures grown
for multiple time points
were analyzed. Space limitations imposed
by the large size of the
prescription bottles usually precluded
culturing independent replicates
of all time points or strains.
In the analyses reported here, our goal
was to detect the peritoxins
and precursors in crude culture fluid
samples and characterize
the chromatographic profiles of such samples
without routine quantification
of individual
components.
HPLC-mass spectrometry (MS) analyses of metabolites.
Culture
fluids of the pathogenic strain S+4-1 and the nonpathogenic
strain CSC 9-1 were harvested from prescription bottle cultures at 25 days postinoculation. They were concentrated approximately 1.5- to
2-fold, and 5- to 10-µl samples were analyzed on a Micromass Quatro I
mass spectrometer, utilizing low-resolution positive electrospray
ionization with a probe voltage of 3.5 kV, a cone voltage of 25 V, and
a pepper pot voltage of 400 V. The nebulizer gas was run at 20 liters
of nitrogen h
1, the drying gas was run at 350 liters of nitrogen h
1, and the source
temperature was 100°C. Data acquisition and processing were
controlled by a Micromass MassLynx NT data system. Analytical conditions were the same as those described above for HPLC-DAD analyses, except that a 1- by 150-mm reversed-phase
C18 column (100-Å particle size; Vydac
218TP5115) was used at a flow rate of 50 µl/min. Limits of detection
for the Quatro I were not reported.
 |
RESULTS |
Toxin bioassays.
In all bioassays performed in this study
(Table 1), as well as in experiments with over 50 isolates conducted
during the past 25 years (6, 7, 8, 9, 15, 16, 19, 26, 27;
data not shown), only Tox+ strains were
pathogenic. No exceptions have been observed to the conclusion that
pathogenicity of P. circinata, i.e., the ability to cause root rot and associated disease symptoms beyond small, restricted cortical lesions on the root, absolutely requires the ability to produce peritoxins.
Differential production of peritoxins and precursors by pathogenic
isolates. (i) HPLC-DAD analyses.
Pathogenic strains of
P. circinata produced two known toxins, PtxA and
PtxB, which eluted at 12.1 and 19.1 min, respectively (Fig.
1 and 2).
The biologically inactive precursors PGA, circinatin, and 7-Cl-C eluted
at 18.9, 23.7, and 26.3 min, respectively. The limits of detection for
PtxA, PtxB, PGA, circinatin, and 7-Cl-C were measured as 0.1, 0.1, 0.2, 0.05, and 0.25 µg, respectively. The chromatographic profile of
strain S+4-1 (Fig. 1 and 2) is the recognizable, standard profile that
is typical of pathogenic, toxin-producing strains. We used this same
strain in our previous work (2, 5, 15, 16, 26, 27) for the
analysis, isolation, identification, and structural characterization of
the metabolites produced by P. circinata.
Consequently, regardless of the compression or expansion of the HPLC
profiles that may result from chromatographic variables (such as column
dimensions, gradient elution parameters, etc.), we know the chemical
identity of many of the peaks in the chromatogram because the basic
pattern is consistent. All three Tox+ strains
analyzed in this study (Table 1) exhibited remarkably similar
metabolite profiles even though S+4-1 was isolated from a different
geographic location than were the other two.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
(A) HPLC-DAD chromatograms of metabolites from culture
fluids of representative pathogenic Tox+ and nonpathogenic
Tox isolates, which were cultured in prescription
bottles. The top panel shows the elution pattern of a mixture of
authentic peritoxins and precursors (PtxA, 2.9 µg injected; PGA, 1.8 µg injected; PtxB, 2.1 µg injected; circinatin, 1.2 µg injected;
7-Cl-C, 5.2 µg injected). The chromatogram of culture fluid
metabolites of S+4-1 (Tox+), harvested 20 days
postinoculation, is representative of the metabolite profile of
pathogenic isolates. The bottom panel shows the elution profile of
metabolites harvested 22 days postinoculation from the nonpathogenic
strain CSC 9-1 (Tox ) and is representative of
nonpathogenic isolates. (B) HPLC-DAD chromatograms of the same strains
as in panel A but with the y axis shown at full scale to
highlight differences in production of unknown metabolites (8 to 12 min) by Tox+ and Tox strains, as well as
proportions of unknown and peritoxin-related metabolites. *, unknown
peaks detected in culture fluids of both Tox+ and
Tox strains; #, peaks in culture fluids of the
Tox+ strain that were undetectable in the Tox
strain; x, peaks at 19.7 and 25 min that are unidentified column
contaminants. AU, absorbance units.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
Chromatographic elution of metabolites from culture
fluids of pathogenic Tox+ strains and nonpathogenic
Tox strains, which were grown for 15 days in tissue
culture flasks. Peaks: 1, PtxA; 2, PGA; 3, PtxB; 4, circinatin; 5, 7-Cl-C. A number representing a particular metabolite is indicated only
in profiles where a corresponding peak was clearly evident. The peak at
25 min is an unidentified column contaminant. AU, absorbance units.
|
|
Peaks corresponding to PtxA, circinatin, and 7-Cl-C were not detected
in culture fluids of Tox

strains analyzed by
HPLC-DAD (Fig.
1 and
2). These results were
also observed for replicate
cultures of the Tox

isolate CSC 9-1 grown in
time course experiments in tissue culture
flasks (data not shown). The
same results were observed when CSC
9-1 and all other
Tox

isolates (Table
1) were grown for 20 to 25 days in prescription
bottles or for 15 days in tissue culture flasks
(Fig.
2). Since
PGA and PtxB had retention times (18.9 and 19.1 min,
respectively)
similar to those of unknown compounds produced by
Tox

strains (Fig.
1 and
2), it was sometimes
difficult to rule out
the presence of these compounds in culture fluids
of Tox

strains analyzed by HPLC-DAD.
Comparisons of full-scale chromatographic profiles of metabolites of
Tox
+ and Tox

strains
showed that Tox

strains generally produced
greater amounts of unknown metabolites
eluting between 8 and 12 min
than did Tox
+ strains (Fig.
1B and
2). Many of
the same compounds (based on
elution time) were produced by
Tox
+ strains but in substantially smaller
quantities. The similarities
and differences in the overall metabolite
profiles of the Tox
+ and
Tox

strains suggest that chemical profiling
could be used to determine
the toxin-producing phenotype of
P. circinata strains.
(ii) HPLC-MS analyses.
HPLC-MS (Fig.
3) confirmed that culture fluids of the
pathogenic strain S+4-1 contained ions for all of the known
peritoxin-related compounds. These metabolites, listed in order of
their retention times on the column used for HPLC-MS analyses, are PtxA
(19.4 min), PtxB (26.5 min), PGA (27.1 min), circinatin (30.8 min), and
7-Cl-C (33.2 min). The peritoxin-related compounds were identified by
the presence of their molecular ions [M+H]+ at
the expected retention times and by characteristic isotopic peaks,
which are indicative of the number of chlorine molecules in each
compound (18). For example, the
[M+H]+ of PtxA was 575.2, and the isotopic
peaks detected in the region of this molecular ion were characteristic
for the presence of three chlorine atoms. This pattern of isotopic
peaks and the size of the molecular ion identified the compound eluting
at 19.4 min as PtxA. PtxB and 7-Cl-C exhibited isotopic clusters
characteristic of chlorinated compounds with three or one chlorine
molecule(s), respectively. The isotopic peaks for PGA and circinatin
were typical of nonchlorinated compounds. Molecular ions for each of
the five peritoxin-related metabolites were not detected by select ion monitoring during chromatography of the culture fluids of the nonpathogenic isolate CSC 9-1. Thus, we were unable to detect any
peritoxin-related compounds in strain CSC 9-1 using the HPLC-MS analytical conditions reported here. In combination with the HPLC-DAD data from all of the Tox
strains, as well as
highly sensitive bioassays capable of detecting as little as 1 ng of
peritoxins ml
1, the results suggested that
nonpathogenic strains of P. circinata do not
produce peritoxins or their known precursors.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 3.
Mass spectra recorded at the apex of chromatographic
peaks of the peritoxins and precursors of the Tox+ strain
S+4-1. The spectra are presented, from top to bottom and left to right,
in increasing size of mass and in the proposed order of biosynthesis.
The number shown for each predominant ion is [M+H]+. We
did not detect any peritoxin-related compounds in culture fluids from
the nonpathogenic strain CSC 9-1 when comparable analyses were
conducted (data not shown).
|
|
Conditions for production of peritoxins and precursors.
Production of peritoxins and precursors by the pathogenic,
Tox+ isolate S+4-1, cultured in prescription
bottles, was assayed every 3 to 5 days, starting at 4 days
postinoculation and ending at 46 days postinoculation (Fig.
4). The earliest accumulation of all
peritoxin-related metabolites in prescription bottles was at 8 days
postinoculation. Major peaks in 4-day-old cultures that were observed
prior to the 3.25-min elution time (data not shown) and at 3.9-, 4.5-, 8.9-, and 13.1-min elution times were due to unknown components of the
medium. These compounds were detected at day 0 and were still evident,
but at significantly reduced levels, through 8 days postinoculation.
Production of PtxA and PtxB was comparable at days 20 (32 mg of PtxA
liter
1, 12 mg of PtxB
liter
1) and 25 (28 mg of PtxA
liter
1, 15 mg of PtxB
liter
1) postinoculation. Maximal production of
all peritoxin-related metabolites combined was detected at 25 days
postinoculation, at which time we measured the production of the
peritoxin precursors PGA, circinatin, and 7-Cl-C at quantities of
approximately 17, 30, and 136 mg liter
1,
respectively. PGA and PtxB were generally more difficult to resolve and
detect at all time points than were PtxA and the other precursors. By
41 days postinoculation, peaks for PtxA and PtxB were not clearly
resolved, whereas circinatin and 7-Cl-C were still easily detectable at
46 days postinoculation.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 4.
Time course of peritoxin and precursor production by the
pathogenic, toxin-producing strain S+4-1 cultured in prescription
bottles. Culture fluids were harvested at each time point and analyzed
by HPLC-DAD. The y-axis scale has been adjusted for
easiest viewing of the majority of known and unknown metabolites.
Peaks: 1, PtxA; 2, PGA; 3, PtxB; 4, circinatin; 5, 7-Cl-C. The numbers
with question marks indicate that PtxA and PtxB were not clearly
detected at those time points. The peaks at 19.7 and 25 min are
unidentified column contaminants. AU, absorbance units.
|
|
A time course assay of peritoxin and precursor production in tissue
culture flasks was conducted to determine if such conditions
supported
peritoxin precursor production in both Tox
+ and
Tox

isolates. These experiments were also of
value in examining the
possibility of decreasing culture vessel size
and shortening culture
time without reducing peritoxin production in
Tox
+ isolates. Culture fluids of the pathogenic,
Tox
+ isolate S+4-1 and the nonpathogenic,
Tox

isolate CSC 9-1 were harvested at 4, 6, 8, 12, 16, and 20 days
postinoculation, and samples were analyzed by
gradient HPLC (data
not shown). PtxA, circinatin, and 7-Cl-C were
detected in the
Tox
+ isolate at the earliest
sampling time of 4 days postinoculation.
Maximal production of all
peritoxin-related metabolites occurred
in this isolate by 12 days
postinoculation, although amounts detected
at 16 and 20 days
postinoculation were generally comparable. No
peritoxin-related
metabolites were ever detected in the Tox

isolate CSC 9-1 grown under these
conditions.
Stability of toxin production in P.
circinata.
Pringle and Sheffer (20)
reported that toxin production in P. circinata
was a stable phenotype. However, we detected on numerous occasions and
in all Tox+ isolates analyzed (Table 1)
substantial reductions in the production of PtxA and PtxB after storage
of stock cultures on silica gel at 4°C or in glycerol at
70°C for
more than approximately 3 years. This was the case for cultures grown
and stored at both the Boyce Thompson Institute in Ithaca, N.Y., and
the USDA-Agricultural Research Service laboratory in West Lafayette,
Ind. Pathogenic, toxin-producing strains that became toxin deficient
after storage also exhibited reduced virulence in planta (data not
shown). However, in such peritoxin-deficient isolates, production of
the inactive precursors circinatin and 7-Cl-C was stable, easily
detectable, and, in some cases, greatly increased compared with levels
in pathogenic Tox+ strains. To restore normal
levels of peritoxin production and virulence, the strains were
inoculated onto susceptible sorghum plants, allowed to grow in planta
for several weeks, and then recovered as monoconidial cultures.
 |
DISCUSSION |
Differential production of peritoxin-related metabolites by
pathogenic strains of P. circinata.
A primary goal of this research was to determine whether
Tox
strains of P. circinata synthesize any peritoxin-related metabolites. Using HPLC-DAD analyses (with detection limits ranging from 0.05 to
0.25 µg depending on the metabolite), we could not detect the known
peritoxins or their inactive precursors in six
Tox
strains. Similarly, none of the
peritoxin-related metabolites were detected in culture fluids from a
single Tox
strain analyzed by HPLC-MS.
Additionally, peritoxin activity was not detectable in
Tox
isolates in bioassays that can detect as
little as 1 ng of peritoxin ml
1
(8). These results suggest that the lack of symptom
induction in plants treated with Tox
strains or
their culture fluids is due to an inability to synthesize peritoxins.
One explanation for the lack of toxin production in nonpathogenic
strains is that a mutation in the first gene in the biosynthetic
pathway, or in a regulatory gene, could have caused complete loss
of
peritoxin biosynthesis. Alternatively, the complete biosynthetic
pathway for peritoxin biosynthesis, or a significant portion of
it, may
be absent in Tox

strains. This possibility
would not be surprising given the trend
that is emerging from the
studies of other fungal plant pathogens
(
1,
10,
22,
25,
28) that, like
P. circinata, produce
secondary metabolites that influence host specificity. In these
other
plant-pathogenic fungi, nonpathogenic strains neither produce
toxin nor
carry the genes required for toxin biosynthesis. The
fact that many
genes that determine host specificity are absent
in nonpathogenic races
raises questions regarding the evolution
of pathogenic races of fungi
that produce host-specific toxins.
Horizontal gene transfer has been
proposed as the means by which
genes for host-specific toxin
biosynthesis are acquired (
1,
10,
28,
29).
Peritoxin biosynthesis in P.
circinata.
The peritoxins and precursors consist of
two amino acids, a cyclic D-lysine and a
D-aspartic acid, attached to a C10
polyketide unit, which is multiply chlorinated in the active toxins
(2, 8, 15, 16, 26). Experiments monitoring incorporation of 1-[13C]acetate and
1,2-[13C2]acetate
provided evidence for the polyketide origin of the C10 moiety in circinatin and PtxA and PtxB
(2; D. Arigoni, personal communication). The observed
incorporation pattern suggested that circinatin is a precursor of the
chlorinated compounds. This hypothesis was supported by the isolation
of the monochloro derivative of circinatin, 7-Cl-C, from culture fluids
of P. circinata (Fig. 3) (5; Macko and Arigoni, unpublished).
We suggest the following biosynthetic relationships among the known
peritoxin-related metabolites: PGA is proposed as an early
precursor
from which circinatin, 7-Cl-C, PtxB, and PtxA are synthesized
in that
order. Precursors of PGA, as well as other intermediates
involved in the conversion of PGA to circinatin or 7-Cl-C to PtxB,
likely exist. Such precursors and intermediates may be labile,
degraded, or rapidly converted or may accumulate in extremely
low
quantities that are undetectable by the analytical methods
that we have
employed.
Knowledge of the structures and synthesis of the peritoxins and
precursors allows us to predict the kinds of genes that are
required
for biosynthesis of these compounds. Because the known
peritoxin-related metabolites consist of two modified nonprotein
amino
acids linked to a C
10 polyketide moiety, we
predict that
a peptide synthetase (
17) and a polyketide
synthase (
12) are
key enzymes required for biosynthesis.
Both enzymes are multifunctional,
multidomain enzymes that catalyze the
synthesis of complex nonribosomally
synthesized peptides or
polyketides, respectively. Since the C
10 polyketide moiety of 7-Cl-C and the peritoxins is chlorinated,
a
chloroperoxidase or some other type of novel halogenase
(
24)
is predicted to be required as
well.
Optimal culture conditions for production of peritoxin-related
metabolites.
In vitro production of peritoxins by P. circinata is dependent, at least in part, on physical
conditions that are not well understood. For example, peritoxin
production is not detected in aerated shake cultures and is suppressed
in standing cultures grown in Erlenmeyer flasks, while production of
the precursor circinatin is significantly enhanced under these growth
conditions (15). In contrast, peritoxin accumulation is
relatively abundant in stale standing cultures grown in glass Roux or
prescription bottles (20, 26). In the studies reported
here, a secondary goal was to scale down the size of culture vessels
while maintaining optimal peritoxin production by
Tox+ isolates. We designed culture conditions to
maintain the surface-area-to-volume ratio provided in the prescription bottles.
Toxin production by pathogenic strains of
P. circinata was consistently good when the fungus was grown in
prescription bottles
for at least 20 to 25 days (
16,
20).
The production of peritoxins
and precursors in tissue culture flasks
was usually comparable
to, and sometimes better than, production in
prescription bottles,
with generally less variability among replicates.
Tissue culture
flasks have several advantages over prescription bottles
for peritoxin
production: they are disposable and smaller and can be
stacked,
contamination problems are less likely, and the time to
maximal
peritoxin production is reduced by about 1
week.
Even when peritoxin production in Tox
+ isolates
was reduced as a result of changes in strains during storage or
unfavorable
culture conditions, circinatin and 7-Cl-C were easily
detected.
Thus, we hypothesize that circinatin production is
consistently
and specifically associated with
Tox
+ genotypes and that circinatin production can
be used as a reliable
phenotypic marker to distinguish
Tox
+ and Tox

strains or
mutants, as long as at least small amounts of PtxA
are
detectable.
The development of efficient and reproducible methods for culturing and
analyzing
P. circinata for in vitro production of
the peritoxins and precursors will increase the number of strains
that
can be screened and enable the identification of mutants
with targeted
disruptions in peritoxin biosynthetic genes. Ultimately,
such efforts
are expected to lead to the cloning of genes responsible
for peritoxin
biosynthesis.
 |
ACKNOWLEDGMENTS |
We thank Heather McLane and Mark McClenning for technical
assistance and D. Arigoni and his colleagues at the ETH in
Zürich, Switzerland, for their long-standing and valuable collaboration.
This work was supported in part by a grant to A.C.L.C. from the Park
Foundation, Ithaca, N.Y. MS analyses were conducted by the Mass
Spectrometry Laboratory, School of Chemical Sciences, University of
Illinois, supported in part by a grant from the National Institute of
General Medical Sciences (GM 27029). The Quatro mass spectrometer was
purchased in part with a grant from the Division of Research Resources,
National Institutes of Health (RR 07141).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Boyce Thompson
Institute, Cornell University, Tower Rd., Ithaca, NY 14853-1801. Phone: (607) 254-1355. Fax: (607) 254-2958. E-mail: acc7{at}cornell.edu.
Present address: Department of Medicine, University of Rochester,
Rochester, NY 14607.
Present address: Oridigm Corporation, Seattle, WA 98103-8012.
 |
REFERENCES |
| 1.
|
Ahn, J.-H., and J. D. Walton.
1996.
Chromosomal organization of TOX2, a complex locus controlling host-selective toxin biosynthesis in Cochliobolus carbonum.
Plant Cell
8:887-897[Abstract].
|
| 2.
|
Bänteli, R.
1993.
Beiträge zur Strukturaufklärung und Studien zur Biosynthese der Metaboliten von Periconia circinata. Thesis.
Swiss Federal Institute of Technology, Zürich, Switzerland.
|
| 3.
|
Canada, S. R., and L. D. Dunkle.
1997.
Polymorphic chromosomes bearing the Tox2 locus in Cochliobolus carbonum behave as homologs during meiosis.
Appl. Environ. Microbiol.
63:996-1001[Abstract].
|
| 4.
|
Chang, H.-R., and C. R. Bronson.
1996.
A reciprocal translocation and possible insertion(s) tightly associated with host-specific virulence in Cochliobolus heterostrophus.
Genome
39:549-557.
|
| 5.
|
Churchill, A. C. L.,
J. Wang,
V. Macko, and L. D. Dunkle.
1998.
Biosynthesis of the host-specific peritoxins from Periconia circinata.
Phytopathology
88:S17.
|
| 6.
|
Dunkle, L. D.
1979.
Heterogeneous reaction of shattercane to Periconia circinata and its host-specific toxin.
Phytopathology
69:260-262.
|
| 7.
|
Dunkle, L. D.
1992.
Periconia, p. 137-141.
In
L. Singleton, J. D. Mihail, and C. Rush (ed.), Methods for research on soilborne phytopathogenic fungi. APS Press, St. Paul, Minn.
|
| 8.
|
Dunkle, L. D., and V. Macko.
1995.
Peritoxins and their effects on sorghum.
Can. J. Bot.
73S:S444-S452.
|
| 9.
|
Dunkle, L. D., and T. J. Wolpert.
1981.
Independence of milo disease symptoms and electrolyte leakage induced by the host-specific toxin from Periconia circinata.
Physiol. Plant Pathol.
18:315-323.
|
| 10.
|
Johnson, R. D.,
L. Johnson,
Y. Itoh,
M. Kodama,
H. Otani, and K. Kohmoto.
2000.
Cloning and characterization of a cyclic peptide synthetase gene from Alternaria alternata apple pathotype whose product is involved in AM-toxin synthesis and pathogenicity.
Mol. Plant-Microbe Interact.
13:742-753[Medline].
|
| 11.
|
Keller, N. P., and T. M. Hohn.
1997.
Metabolic pathway gene clusters in filamentous fungi.
Fungal Genet. Biol.
21:17-29[CrossRef][Medline].
|
| 12.
|
Khosla, C.,
R. S. Gokhale,
J. R. Jacobsen, and D. E. Cane.
1999.
Tolerance and specificity of polyketide synthases.
Annu. Rev. Biochem.
68:219-253[CrossRef][Medline].
|
| 13.
|
Kodama, M.,
M. S. Rose,
G. Yang,
S. H. Yun,
O. C. Yoder, and B. G. Turgeon.
1999.
The translocation-associated Tox1 locus of Cochliobolus heterostrophus is two genetic elements on two different chromosomes.
Genetics
151:585-596[Abstract/Free Full Text].
|
| 14.
|
Leukel, R. W.
1948.
Periconia circinata and its relation to milo disease.
J. Agric. Res.
77:201-222.
|
| 15.
|
Macko, V.,
M. B. Stimmel,
H. Peeters,
T. J. Wolpert,
L. D. Dunkle,
W. Acklin,
R. Bänteli,
B. Jaun, and D. Arigoni.
1990.
The structure of circinatin, a non-toxic metabolite from the plant pathogenic fungus Periconia circinata.
Experientia
46:1206-1209[CrossRef].
|
| 16.
|
Macko, V.,
M. B. Stimmel,
T. J. Wolpert,
L. D. Dunkle,
W. Acklin,
R. Bänteli,
B. Jaun, and D. Arigoni.
1992.
Structure of the host-specific toxins produced by the fungal pathogen Periconia circinata.
Proc. Natl. Acad. Sci. USA
89:9574-9578[Abstract/Free Full Text].
|
| 17.
|
Marahiel, M. A.,
T. Stachelhaus, and H. D. Mootz.
1997.
Modular peptide synthetases involved in nonribosomal peptide synthesis.
Chem. Rev.
97:2651-2673[CrossRef][Medline].
|
| 18.
|
McLafferty, F. W., and F. Turecek.
1993.
Interpretation of mass spectra, 4th ed.
University Science Books, Mill Valley, Calif.
|
| 19.
|
Odvody, G. N.,
L. D. Dunkle, and L. K. Edmunds.
1977.
Characterization of the Periconia circinata population in a milo disease nursery.
Phytopathology
67:1485-1489.
|
| 20.
|
Pringle, R. B., and R. P. Scheffer.
1963.
Purification of the selective toxin of Periconia circinata.
Phytopathology
53:785-787.
|
| 21.
|
Schertz, K. F., and Y. P. Tai.
1969.
Inheritance of reaction of Sorghum bicolor (L.) Moench to toxin produced by Periconia circinata (Mang.) Sacc.
Crop Sci.
9:621-624[Abstract/Free Full Text].
|
| 22.
|
Tanaka, A.,
H. Shiotani,
M. Yamamoto, and T. Tsuge.
1999.
Insertional mutagenesis and cloning of the genes required for biosynthesis of the host-specific AK-toxin in the Japanese pear pathotype of Alternaria alternata.
Mol. Plant-Microbe Interact.
12:691-702[Medline].
|
| 23.
|
Traylor, E. A.,
L. D. Dunkle, and K. F. Schertz.
1988.
Pathotoxin-induced alterations in protein synthesis associated with susceptibility of sorghum to milo disease.
Crop Sci.
28:615-617[Abstract/Free Full Text].
|
| 24.
|
van Pée, K.-H.,
S. Keller,
T. Wage,
I. Wynands,
H. Schnerr, and S. Zehner.
2000.
Enzymatic halogenation catalyzed via a catalytic triad and by oxidoreductases.
Biol. Chem.
381:1-5[CrossRef][Medline].
|
| 25.
|
Walton, J. D.
1996.
Host-selective toxins: agents of compatibility.
Plant Cell
8:1723-1733[CrossRef][Medline].
|
| 26.
|
Wolpert, T. J., and L. D. Dunkle.
1980.
Purification and partial characterization of host-specific toxins produced by Periconia circinata.
Phytopathology
70:872-876.
|
| 27.
|
Wolpert, T. J., and L. D. Dunkle.
1983.
Alterations in gene expression in sorghum induced by the host-specific toxin from Periconia circinata.
Proc. Natl. Acad. Sci. USA
80:6576-6580[Abstract/Free Full Text].
|
| 28.
|
Yang, G.,
M. S. Rose,
B. G. Turgeon, and O. C. Yoder.
1996.
A polyketide synthase is required for fungal virulence and production of the polyketide T-toxin.
Plant Cell
8:2139-2150[Abstract].
|
| 29.
|
Yoder, O. C.
1998.
A mechanistic view of the fungal/plant interaction based on host-specific toxin studies, p. 3-15.
In
K. Kohmoto, and O. C. Yoder (ed.), Molecular genetics of host-specific toxins in plant disease. Kluwer Academic Publishers, Dordrecht, The Netherlands.
|
Applied and Environmental Microbiology, December 2001, p. 5721-5728, Vol. 67, No. 12
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.12.5721-5728.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.